SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000950142-00-000588
Filing Date
2000-07-07
Accepted
2000-07-07 00:00:00
Documents
4
Group Members
FRANK H. PEARL (IN THE CAPACITY DESCRIBED HEREIN)GEORGE SOROS (IN THE CAPACITY DESCRIBED HEREIN)PSV, LP F/K/A PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LPSFM AH, INC.SFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT L.L.C.SOROS GEORGESTANLEY F. DRUCKENMILLER (IN T

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D 0001.txt SC 13D/A 39857
2 JOINT FILING AGREEMENT 0002.txt EX-1 4843
3 POWER OF ATTORNEY 0003.txt EX-2 2448
4 POWER OF ATTORNEY 0004.txt EX-3 2468
  Complete submission text file 0000950142-00-000588.txt   52691
Mailing Address 888 SEVENTH AVE 33RD FLR NEW YORK NY 10106
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 212-262--6
SOROS GEORGE (Filed by) CIK: 0000900203 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
SIC: 0000

Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Subject) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-48239 | Film No.: 669340
SIC: 2834 Pharmaceutical Preparations